CME Group Inc. $CME Shares Bought by Nordea Investment Management AB

Nordea Investment Management AB boosted its position in CME Group Inc. (NASDAQ:CME) by 11.5% during the third quarter, Holdings Channel.com reports. The institutional investor owned 36,333 shares of the financial services provider’s stock after purchasing an additional 3,758 shares during the period. Nordea Investment Management AB’s holdings in CME Group were worth $9,901,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in shares of CME Group by 1.5% in the 2nd quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock valued at $9,695,313,000 after acquiring an additional 532,549 shares during the last quarter. Geode Capital Management LLC lifted its position in CME Group by 3.6% during the second quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock valued at $2,524,271,000 after purchasing an additional 319,899 shares during the period. Norges Bank purchased a new stake in CME Group in the second quarter valued at $1,571,447,000. Ameriprise Financial Inc. grew its position in CME Group by 2.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock worth $1,289,910,000 after purchasing an additional 92,925 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its position in CME Group by 6.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock worth $1,056,476,000 after purchasing an additional 238,522 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME plans to add Cardano (ADA), Chainlink (LINK) and Stellar (XLM) futures — standard and micro contracts — boosting crypto product breadth and capital‑efficient tools for clients; listing targeted for Feb. 9 pending review, which could lift futures trading volumes and fee revenue. CME Group Expands Crypto Futures With Cardano, Chainlink, and Stellar
• Positive Sentiment: TD Cowen upgraded CME to “Buy”, signaling constructive analyst sentiment that supports upside and likely helped investor confidence. TD Cowen Upgrades CME Group (NASDAQ:CME) to “Buy”
• Positive Sentiment: CME is introducing a new, smaller silver futures contract to capture surging retail interest in silver — a product move that can broaden participation and boost notional volumes in metals. Silver Gets a Major Upgrade: CME to Launch New Futures as Retail Demand Hits Record Levels
• Neutral Sentiment: Jefferies trimmed its price target slightly (from $304 to $302) but kept a “Buy” rating — modestly lowering upside but still supportive. Jefferies Adjusts Price Target on CME Group
• Neutral Sentiment: Morgan Stanley cut its price target by $1 to $319 while retaining an “Overweight” rating — a slight tweak that keeps a bullish stance but marginally lowers modeled upside. Morgan Stanley Lowers CME Price Target
• Neutral Sentiment: Analyst previews and coverage notes (e.g., “Here’s What to Expect From CME Group’s Next Earnings Report”) keep focus on volumes/fee trends and macro volatility — useful context but not immediate catalysts. Here’s What to Expect From CME Group’s Next Earnings Report
• Negative Sentiment: Goldman Sachs nudged its target slightly lower (from $265 to $264) and maintains a “Sell” rating — a visible negative outlier that can weigh on sentiment among more cautious investors. Goldman Sachs Adjusts CME Group Price Target

CME Group Stock Up 2.5%

CME Group stock opened at $279.44 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $100.77 billion, a PE ratio of 27.08, a price-to-earnings-growth ratio of 3.08 and a beta of 0.27. The business has a 50 day simple moving average of $274.20 and a 200-day simple moving average of $271.84. CME Group Inc. has a 12 month low of $230.19 and a 12 month high of $290.79.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business’s revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.68 EPS. On average, analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were given a $1.25 dividend. The ex-dividend date was Friday, December 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is 48.45%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. TD Cowen raised CME Group from a “hold” rating to a “buy” rating and boosted their price objective for the company from $290.00 to $305.00 in a report on Wednesday. Rothschild & Co Redburn lifted their price target on CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a research report on Thursday, November 6th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $275.00 to $300.00 in a report on Thursday, September 25th. Jefferies Financial Group dropped their price objective on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a research note on Monday, January 12th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $310.00 to $318.00 and gave the company a “buy” rating in a report on Wednesday, December 17th. Ten investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $291.82.

Insider Transactions at CME Group

In related news, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the completion of the transaction, the director owned 1,091 shares in the company, valued at $287,511.23. This represents a 47.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the transaction, the chief executive officer directly owned 65,804 shares in the company, valued at $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.